Commentary
The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies
Abstract
In the last half-century, impressive developments in molecular and genetic techniques has provided us with powerful tools for evaluation and decision making in the diagnosis, treatment, and follow-up of breast cancer patients.
